Donepezil treatment improves cognitive performance in patients with very mild Alzheimer's disease

被引：0
|
作者：
Seltzer, B
Zolnouni, P
Nunez, M
Goldman, R
Noble, Y
Kumar, D
Griesing, T
Richardson, S
机构：
[1] Tulane Univ, Sch Med, New Orleans, LA 70118 USA
[2] CA Clin Trials Med Grp, Beverly Hills, CA USA
[3] ICSL Clin Studies, St Petersburg, FL USA
[4] Pfizer Inc, New York, NY USA
[5] Eisai Inc, Teaneck, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2002年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 50 条
  • [31] Atorvastatin does not slow cognitive decline in patients with mild to moderate probable Alzheimer's disease who are taking donepezil
    Feldman, Howard
    Fillit, Howard
    EVIDENCE-BASED MENTAL HEALTH, 2010, 13 (04) : 117 - 117
  • [32] SPECT-Identified Neuroanatomical Predictor of the Cognitive Effects of Donepezil Treatment in Patients with Alzheimer's Disease
    Hongo, Jin
    Nakaaki, Shutaro
    Shinagawa, Yoshihiro
    Murata, Yoshie
    Sato, Junko
    Tatsumi, Hiroshi
    Tohyama, Junko
    Soma, Tsutomu
    Iidaka, Tetsuya
    Fukui, Toshiya
    Mimura, Masaru
    Furukawa, Toshiaki A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 26 (06) : 556 - 566
  • [33] Donepezil in the treatment of mild to moderate Alzheimer's disease: report of a Belgian multicenter study
    Santens, P
    Ventura, M
    ACTA NEUROLOGICA BELGICA, 2003, 103 (03) : 159 - 163
  • [34] Combination benefit of cognitive rehabilitation plus donepezil for Alzheimer's disease patients
    Matsuzono, Kosuke
    Hishikawa, Nozomi
    Takao, Yoshiki
    Wakutani, Yosuke
    Yamashita, Toru
    Deguchi, Kentaro
    Abe, Koji
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2016, 16 (02) : 200 - 204
  • [35] Donepezil for the treatment of agitation in Alzheimer's disease
    Howard, Robert J.
    Juszczak, Edmund
    Ballard, Clive G.
    Bentham, Peter
    Brown, Richard G.
    Bullock, Roger
    Burns, Alistair S.
    Holmes, Clive
    Jacoby, Robin
    Johnson, Tony
    Knapp, Martin
    Lindesay, James
    O'Brien, John T.
    Wilcock, Gordon
    Katona, Cornelius
    Jones, Roy W.
    DeCesare, Julia
    Rodger, Michaela
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1382 - 1392
  • [36] Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease
    Gauthier, S
    Feldman, H
    Hecker, J
    Vellas, B
    Emir, B
    Subbiah, P
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : 347 - 354
  • [37] Hormonal treatment, mild cognitive impairment and Alzheimer's disease
    Ryan, Joanne
    Scali, Jaqueline
    Carriere, Isabelle
    Ritchie, Karen
    Ancelin, Marie-Laure
    INTERNATIONAL PSYCHOGERIATRICS, 2008, 20 (01) : 47 - 56
  • [38] Significant behavioral benefits with continued donepezil treatment in patients with mild-to-moderate Alzheimer's disease.
    Nunez, M
    Barcikowska, M
    Dautzenberg, P
    Heun, R
    Jakobsen, S
    Karageorgiou, C
    Triau, E
    Tury, F
    Qvitzau, S
    Richardson, S
    Xu, Y
    Schwam, E
    Schindler, R
    Johannsen, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S76 - S76
  • [39] Current treatment of mild cognitive impairment and Alzheimer's disease
    Knopman, David S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (05) : 365 - 371
  • [40] Current treatment of mild cognitive impairment and alzheimer’s disease
    David S. Knopman
    Current Neurology and Neuroscience Reports, 2006, 6 : 365 - 371
12345